Novartis to invest $300M to boost development of next-gen biotherapeutics
Novartis (NVS) said on Sept. 12 that it is investing $300M to bolster its capacity and capabilities for early technical development of biologics, and…
Novartis to invest $300M to boost development of next-gen biotherapeutics
Novartis (NVS) said on Sept. 12 that it is investing $300M to bolster its capacity and capabilities for early technical development of biologics, and…